41Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin: retrospective analysis
Takano M, Sugiyama T, Yaegashi N, Suzuki M, Tsuda H, Sagae S, Udagawa Y, Kuzuya K, Kigawa J, Takeuchi S, Tsuda H, Moriya T, Kikuchi Y
2007Int J Clin Oncol 12256-260
42Can ABCF2 protein expression predict the prognosis of uterine cancer?
Nishimura S, Tsuda H, Miyagi Y, Hirasawa A, Suzuki A, Kataoka F, Nomura H, Chiyoda T, Banno K, Fujii T, Susumu N, Aoki D
2008Br J Cancer 991651-1655
43Phase 2 clinical trial of pegylated liposomal doxorubicin（JNS002） in Japanese patients with Mullerian carcinoma （epithelian ovarian carcinoma, primary carcinoma of fallopian tube, peritoneal carcinoma） having a therapeutic history of platinum-based chemotherapy : A phase II study of the Japanese Gynecologic Oncology Group
Katsumata N, Fujiwara Y, Kamura T, Nakanishi T, Hatae M, Aoki D, Tanaka K, Tsuda H, Kamiura S, Takehara K, Sugiyama T, Kigawa J, Fujiwara K, Ochiai K, Ishida R, Inagaki M, Noda K
2008Jpn J Clin Oncol 38775-785
44Germ cell specific protein VASA is overexpressed in epithelial ovarian cancer and disrupts DNA damage-induced G2 checkpoint
Hashimoto H, Sudo T, Mikami Y, Otani M, Takano M, Tsuda H, Itamochi H, Katabuchi H, Ito M, Nishimura R
2008Gynecologic Oncol 111312-319
45A randomized phase III trials of "dose-dense" weekly paclitaxel in combination with carboplatin for advanced ovarian cancer
Katsumata N, Yasuda M, Takahashi F, Isonishi S, Jobo T, Aoki D, Tsuda H, Sugiyama T, Kodama S, Kimura E, Ochiai K, Noda K
2009Lancet 3741331-1338
46The impact of complete surgical staging upon survival in early-stage ovarian clear cell carcinoma
Takano M, Sugiyama T, Yaegashi N, Suzuki M, Tsuda H, Sagae S, Udagawa Y, Kuzuya K, Kigawa J, Takeuchi S, Tsuda H, Moriya T, Kikuchi Y
2009Int J Gynecol Cancer 191353-1357
47Differential expression of hypoxia-inducible 2 （HIG2） protein among different histologic types of epithelial ovarian cancer and in clear cell adnocarcinoma
Nishimura S, Tsuda H, Ito K, Takano M, Sudo T, Terai Y, Jobo T, Kigawa J, Sugiyama T, Yaegashi N, Aoki D
2010Int J Gynecol Cancer 20220-226
48The sensitivity and specificity of new formula to distinguish endometrioid type endometrial carcinoma from ovarian endometrial carcinoma
Nishimura S, Ito YM, Tsuda H, Ohnishi Y, Kataoka F, Susumu N, Aoki D, Hatae M
2010Eur J Obstet Gynecol 1467-72
49Identification of potential serum markers for endometrial cancer using protein expression profiling
Takano M, Kikuchi Y, Asakawa T, Goto T, Kita T, Kudoh K, Kigawa J, Sakuragi N, Sakamoto M, Sugiyama T, Yaegashi N, Tsuda H, Seto H, Shiwa M
2010J Cancer Res Clin Oncol 136475-481
50Effects of third line chemotherapy for women with recurrent ovarian cancer who received platinum/taxane regimens as first line chemotherapy
Chiyoda T, Tsuda H, Nomura H, Kataoka F, Tominaga E, Suzuki A, Susumu N, Aoki D
